NeuroFlow Closes $20M Series B Investment

Lead investment from Magellan Health highlights pressing need for tech-enabled behavioral health integration and collaborative care solutions NeuroFlow, the market leader in solutions supporting technology-enabled behavioral health integration, announces today the initial closing of a $20M Series B financing round led by Magellan Health (NASDAQ: MGLN), in addition to a syndicate including previous investors. Magellan … Continue reading NeuroFlow Closes $20M Series B Investment